全文获取类型
收费全文 | 153篇 |
免费 | 5篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 2篇 |
妇产科学 | 3篇 |
基础医学 | 16篇 |
口腔科学 | 2篇 |
临床医学 | 11篇 |
内科学 | 41篇 |
皮肤病学 | 5篇 |
神经病学 | 4篇 |
特种医学 | 4篇 |
外科学 | 16篇 |
综合类 | 4篇 |
预防医学 | 9篇 |
眼科学 | 2篇 |
药学 | 26篇 |
中国医学 | 2篇 |
肿瘤学 | 11篇 |
出版年
2023年 | 4篇 |
2022年 | 8篇 |
2021年 | 14篇 |
2020年 | 13篇 |
2019年 | 8篇 |
2018年 | 19篇 |
2017年 | 4篇 |
2016年 | 8篇 |
2015年 | 3篇 |
2014年 | 6篇 |
2013年 | 13篇 |
2012年 | 14篇 |
2011年 | 18篇 |
2010年 | 8篇 |
2009年 | 8篇 |
2008年 | 1篇 |
2006年 | 2篇 |
2005年 | 2篇 |
2004年 | 1篇 |
2003年 | 3篇 |
2002年 | 1篇 |
1987年 | 1篇 |
排序方式: 共有159条查询结果,搜索用时 15 毫秒
1.
Comparative Cytotoxicity of Glycyrrhiza glabra Roots from Different Geographical Origins Against Immortal Human Keratinocyte (HaCaT), Lung Adenocarcinoma (A549) and Liver Carcinoma (HepG2) Cells 下载免费PDF全文
Norazah Basar Olayinka Ayotunde Oridupa Kenneth J. Ritchie Lutfun Nahar Nashwa Mostafa M. Osman Angela Stafford Habibjon Kushiev Asuman Kan Satyajit D. Sarker 《Phytotherapy research : PTR》2015,29(6):944-948
Glycyrrhiza glabra L. (Fabaceae), commonly known as ‘liquorice’, is a well‐known medicinal plant. Roots of this plant have long been used as a sweetening and flavouring agent in food and pharmaceutical products, and also as a traditional remedy for cough, upper and lower respiratory ailments, kidney stones, hepatitis C, skin disorder, cardiovascular diseases, diabetes, gastrointestinal ulcers and stomach ache. Previous pharmacological and clinical studies have revealed its antitussive, antiinflammatory, antiviral, antimicrobial, antioxidant, immunomodulatory, hepatoprotective and cardioprotective properties. While glycyrrhizin, a sweet‐tasting triterpene saponin, is the principal bioactive compound, several bioactive flavonoids and isoflavonoids are also present in the roots of this plant. In the present study, the cytotoxicity of the methanol extracts of nine samples of the roots of G. glabra, collected from various geographical origins, was assessed against immortal human keratinocyte (HaCaT), lung adenocarcinoma (A549) and liver carcinoma (HepG2) cell lines using the in vitro 3‐[4,5‐dimethylthiazol‐2‐yl]‐2,5‐diphenyl tetrazoliumbromide cell toxicity/viability assay. Considerable variations in levels of cytotoxicity were observed among various samples of G. glabra. Copyright © 2015 John Wiley & Sons, Ltd. 相似文献
2.
Yasser Emad Yasser Ragab Nashwa El-Shaarawy Johannes J. Rasker 《Clinical rheumatology》2012,31(11):1641-1647
Transient osteoporosis of the hip (TOH), also referred to as transient bone marrow edema syndrome, is most common in middle-aged men and often after trivial trauma or sport-related injuries. Diagnosis is usually made by eliminating other possible causes of hip pain. Magnetic resonance imaging (MRI) plays an important role in diagnosis and demonstrates a typical pattern of bone marrow edema (BME) in the form of diffuse low signal on T1-weighted images and high signal on T2 fat-suppressed or short T1 inversion recovery images. No consensus exists about the management of TOH, as it may progress to avascular necrosis. We describe eight cases of TOH treated with alendronate resulting in improvement of pain and function and complete resolution of BME on MRI. The literature is reviewed regarding TOH and the relationship with bone marrow edema syndrome, avascular necrosis of the hip, and regional migratory osteoporosis. To our knowledge, this is the first report describing the improvement of this condition after of alendronate with documented radiological improvement on follow-up MRI. 相似文献
3.
4.
5.
Zinc oxide nanoparticles (ZnO NPs) therapy is a promising strategy for treatment of several diseases. We aimed to investigate the therapeutic potential of ZnO NPs in ameliorating the histopathological and functional alterations in the pancreas of a rat model of streptozotocin-induced diabetes. Rats were randomized into control, diabetic and ZnO NPs-treated diabetic groups. Biochemical assays of blood glucose and serum insulin were performed. Pancreas specimens were processed for light and electron microscope examinations. ZnO NPs effectively reversed diabetes-induced pancreatic injury, as evidenced by the structural and ultrastructural improvement and confirmed by biochemical normalization of blood glucose and serum insulin. 相似文献
6.
Yasser Emad Ashraf Anbar Ihab Abo-Elyoun Nashwa El-Shaarawy Hadeel Al-Hanafi Hatem Darwish Mona Gamil Johannes J. Rasker 《Clinical rheumatology》2014,33(6):791-797
This study aimed to determine the frequency of rheumatoid factor (RF) and cyclic citrullinated peptide (CCP) antibodies in a cohort of patients with palindromic rheumatism (PR) and to find determinants for progression to rheumatoid arthritis (RA). All new cases of PR (n?=?90) were included prospectively and followed up for 1 year, and a comparison group of RA cases (n?=?70) was also included. At study entry in all patients in both groups, RF and anti-CCP antibodies were tested, and the findings were compared and correlated. In the PR group at presentation, RF was positive in 30 patients (33.3 %) and, in the RA group, in 45 patients (64.3 %). Anti-CCP antibodies were positive in 35 patients (38.9 %) with PR and in 58 patients (82.9 %) with RA. In the PR group, positive correlations were observed between RF and C-reactive protein (CRP) (p?=?0.036), while anti-CCP positively correlated with disease duration (p?=?0.015) and CRP (p?<?0.001). At 1-year follow-up, 25 cases (27.5 %) had progressed to RA, 3 (3.3 %) cases had developed systemic lupus, 43 cases had responded to hydroxychloroquine with complete remission, five cases had developed other rheumatic diseases, and 14 cases had progressed to undifferentiated arthritis. After regression analysis, the involvement of hand joints and positive anti-CCP were the only predictors that determined progression into RA within a year (p?<?0.001 and p?=?0.02, respectively). Early hand joint involvement and positive anti-CCP at disease onset are good predictors for progression to RA in this domain. 相似文献
7.
Khedr Eman M. El Fetoh Noha Abo Gamal Rania M. Elzohri Mona H. Azoz Nashwa Mostafa A. Furst Daniel E. 《Clinical rheumatology》2020,39(5):1551-1559
Clinical Rheumatology - To investigate cognitive dysfunction in adult patients with systemic sclerosis (SSc) who had no known clinical neurological manifestations and to relate it with other... 相似文献
8.
9.
Aref M. Maarouf Salem Khalil Emad A. Salem Mahmoud ElAdl Nashwa Nawar Fatma Zaiton 《BJU international》2011,107(10):1605-1610
Study Type – Therapy (case series) Level of Evidence 4 What’s known on the subject? and What does the study add? The subject of bladder preservation multimodality protocols in muscle invasive bladder TCC is not new. In our study, even in a highly selected group of patients, multimodality protocol with M‐VAC and radiation therapy achieved suboptimal results at 1 year. This emphasized the role of radical cystectomy as the gold standard treatment for invasive bladder TCC.
OBJECTIVE
- ? To evaluate the efficacy of a bladder preservation multimodality protocol for patients with operable carcinoma invading bladder muscle.
MATERIALS AND METHODS
- ? In this prospective study, we included 33 patients with transitional cell carcinoma (TCC) (T2 and T3, Nx, M0) who were amenable to complete transurethral resection.
- ? These patients refused radical cystectomy as their first treatment option. After maximum transurethral resection of bladder tumour (TURBT), all patients received three cycles of adjuvant chemotherapy in the form of methotrexate, vinblastin, adriamycin and cisplatin (MVAC) followed by radical radiotherapy.
- ? Four weeks later, all cases had radiological and cystoscopical re‐evaluation.
- ? Complete responders were considered to be those patients who had no evidence of residual tumour. All patients were subjected to a regular follow‐up by cystoscopy and tumour site biopsy conducted every 3 months. Abdomino‐pelvic computed tomography and chest X‐ray were conducted every 6 months.
- ? The study endpoint was the response to treatment after completion of the first year of follow‐up after therapy.
RESULTS
- ? Out of 33 eligible patients, a total of 28 patients completed the study treatment protocol. Their mean ± SD age was 56.7 ± 6 years. Trimodal therapy was well tolerated in most of cases, with no severe acute toxicities. After 12 months of follow‐up, a complete response was achieved in 39.3% and a partial response in 7.1%, with an overall response rate of 46.4%.
- ? By the end of the first year, disease‐free survival was reported in 39.3%, whereas 25% were still alive with their disease, giving an overall survival of 64.3% for all patients who maintained their intact, well functioning bladders.
- ? Tumour stage and completeness of transurethral resection of bladder tumour were the most important predictors of response and survival. T2 lesions had complete and partial response rates of 69.2% and 23%, respectively, whereas T3 lesions had rates of 40% and 13.3%, respectively (P= 0.001).
- ? The response rate in patients who had complete TURBT was 82.6% vs 20% in those with cystoscopic biopsy only (P= 0.001). In addition, disease‐free survival was 72.7% in T2 patients and 27.3% in T3 patients (P= 0.001).
CONCLUSION
- ? In the present study, bladder preservation protocol with MVAC and radical radiotherapy achieved suboptimal response rates at 1 year in patients with localized TCC invading bladder muscle. Patients with solitary T2 lesions that are amenable to complete TURBT achieved the best response rates. Longer follow‐up is needed to verify these results. Patients with localized disease should be encouraged for radical cystectomy, which achieved better results.
10.